August 04, 2022
- Vial adds Dr Luke Nordquist to company's Oncology Scientific Advisory Board.
- Amgen names new Director.
- Ascletis Pharma's ASC10 IND application for COVID-19 receives Chinese regulatory approval.
- Jubilant Therapeutics' JBI-778 IND application receives US FDA approval to treat solid tumours with brain metastases and primary brain tumours.
- Avenge Bio's AVB-001 IND application receives US FDA approval for peritoneal malignancies.
- GreatAmerica withdraws industrial banking license application.
- Bank of America hires banker from Credit Suisse.
- Credit Agricole reports profit increase.
- World Bank accuses Lebanese politicians of cruelty for false deposit promises.